New Delhi: The Union Ministry of Health and Family Welfare has proposed significant amendments to the Drugs Rules, 1945, aiming to bolster the quality and distribution of pharmaceutical products across India.
These changes include incorporating Good Storage and Distribution Practices (GSDP) and providing regulatory flexibility for certain drug categories under the revised Schedule M framework.
The proposed GSDP framework is designed to ensure that the quality, safety, efficacy, and integrity of medicines are maintained at every step, from manufacturers and importers right up to the patients. This means stricter guidelines for procurement, purchasing, storage, transportation, documentation, and record-keeping, ensuring that the medicines reaching people are safe and effective.
In a move to address industry concerns, the ministry has also proposed amending provisions of the revised Schedule M for medicinal gases, empty gelatin capsules, and disinfectant fluids. Stakeholders had highlighted that some manufacturing requirements under Schedule M were not relevant to these specific products. The Drugs Technical Advisory Board (DTAB) reviewed these concerns in February 2026 and agreed that flexibility was needed.
These amendments, published in a draft Gazette Notification, aim to strike a balance between stringent quality control and practical regulatory flexibility for the pharmaceutical industry. This ensures that essential medicines and related products are not only of high quality but also readily available to the public without unnecessary hurdles for manufacturers.